OCRA News New Bioinformatics Tool Shows Promise for Matching Cancer Patients with Optimal Treatment Combinations
Research First Patients Dosed in Phase 2 Platform Clinical Trial Testing Novel Immunotherapy Combinations in Highly Malignant Ovarian Cancer
Research OCRA-Funded Study Pinpoints Partner Proteins That May Contribute to Ovarian Cancer Tumor Growth